|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scharenberg CW, Harkey MA and Torok-Storb
B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump
and is preferentially expressed by immature human hematopoietic
progenitors. Blood. 99:507–512. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast
cancer cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang D, Nguyen TK, Leishear K, Finko R,
Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
|
7
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: Implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naka N, Takenaka S, Araki N, Miwa T,
Hashimoto N, Yoshioka K, Joyama S, Hamada K, Tsukamoto Y, Tomita Y,
et al: Synovial sarcoma is a stem cell malignancy. Stem Cells.
28:1119–1131. 2010.PubMed/NCBI
|
|
9
|
Zoller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang X, Gwye Y, Russell D, Cao C, Douglas
D, Hung L, Kovar H, Triche TJ and Lawlor ER: CD133 expression in
chemo-resistant Ewing sarcoma cells. BMC Cancer. 10:1162010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Q, Chen ZG, Du CZ, Wang HW, Yan L and
Gu J: Cancer stem cell marker CD133+ tumour cells and clinical
outcome in rectal cancer. Histopathology. 55:284–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Korkaya H and Wicha MS: Selective
targeting of cancer stem cells: A new concept in cancer
therapeutics. BioDrugs. 21:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Honoki K, Fujii H, Kubo A, Kido A, Mori T,
Tanaka Y and Tsujiuchi T: Possible involvement of stem-like
populations with elevated ALDH1 in sarcomas for chemotherapeutic
drug resistance. Oncol Rep. 24:501–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Zhang R, Yan M, Ye Z, Liang W and
Luo Z: Detection and characterization of side population in Ewing's
sarcoma SK-ES-1 cells in vitro. Biochem Biophys Res Commun.
391:1062–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reynolds BA and Weiss S: Generation of
neurons and astrocytes from isolated cells of the adult mammalian
central nervous system. Science. 255:1707–1710. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wilson H, Huelsmeyer M, Chun R, Young KM,
Friedrichs K and Argyle DJ: Isolation and characterisation of
cancer stem cells from canine osteosarcoma. Vet J. 175:69–75. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma
W, Zhang Y, Li C and Zhang S: Spheres derived from the human
SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem
cells. Cancer Lett. 299:150–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murase M, Kano M, Tsukahara T, Takahashi
A, Torigoe T, Kawaguchi S, Kimura S, Wada T, Uchihashi Y, Kondo T,
et al: Side population cells have the characteristics of cancer
stem-like cells/cancer-initiating cells in bone sarcomas. Br J
Cancer. 101:1425–1432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang
R, Li J, Zhang Y, Chen L, Qian H, et al: Sphere-forming cell
subpopulations with cancer stem cell properties in human hepatoma
cell lines. BMC Gastroenterol. 11:712011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawashima H, Ogose A, Gu W, Nishio J, Kudo
N, Kondo N, Hotta T, Umezu H, Tohyama T, Nishijima H, et al:
Establishment and characterization of a novel myxofibrosarcoma cell
line. Cancer Genet Cytogenet. 161:28–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharom FJ: ABC multidrug transporters
Structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gunthert U, Hofmann M, Rudy W, Reber S,
Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P:
A new variant of glycoprotein CD44 confers metastatic potential to
rat carcinoma cells. Cell. 65:13–24. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Naor D, Wallach-Dayan SB, Zahalka MA and
Sionov RV: Involvement of CD44, a molecule with a thousand faces,
in cancer dissemination. Semin Cancer Biol. 18:260–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Michelson S and Slate D: Emergence of the
drug-resistant phenotype in tumor subpopulations: A hybrid model. J
Natl Cancer Inst. 81:1392–1401. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Darnell JE Jr: STATs and gene regulation.
Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Honore SM, Aybar MJ and Mayor R: Sox10 is
required for the early development of the prospective neural crest
in Xenopus embryos. Dev Biol. 260:79–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pesce M and Schöler HR: Oct-4: Gatekeeper
in the beginnings of mammalian development. Stem Cells. 19:271–278.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bourguignon LY, Peyrollier K, Xia W and
Gilad E: Hyaluronan-CD44 interaction activates stem cell marker
Nanog, Stat-3-mediated MDR1 gene expression and ankyrin-regulated
multidrug efflux in breast and ovarian tumor cells. J Biol Chem.
283:17635–17651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Doyle LA, Yang W, Abruzzo LV, Krogmann T,
Gao Y, Rishi AK and Ross DD: A multidrug resistance transporter
from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA.
95:15665–15670. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shukla S, Wu CP and Ambudkar SV:
Development of inhibitors of ATP-binding cassette drug
transporters: Present status and challenges. Expert Opin Drug Metab
Toxicol. 4:205–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim M, Turnquist H, Jackson J, Sgagias M,
Yan Y, Gong M, Dean M, Sharp JG and Cowan K: The multidrug
resistance transporter ABCG2 (breast cancer resistance protein 1)
effluxes Hoechst 33342 and is overexpressed in hematopoietic stem
cells. Clin Cancer Res. 8:22–28. 2002.PubMed/NCBI
|
|
39
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Allikmets R, Schriml LM, Hutchinson A,
Romano-Spica V and Dean M: A human placenta-specific ATP-binding
cassette gene (ABCP) on chromosome 4q22 that is involved in
multidrug resistance. Cancer Res. 58:5337–5339. 1998.PubMed/NCBI
|
|
41
|
Gallatin WM, Weissman IL and Butcher EC: A
cell-surface molecule involved in organ-specific homing of
lymphocytes. Nature. 304:30–34. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ratajczak MZ: Cancer stem cells-normal
stem cells ‘Jedi’ that went over to the ‘dark side’. Folia
Histochem Cytobiol. 43:175–181. 2005.PubMed/NCBI
|
|
43
|
Miraglia S, Godfrey W, Yin AH, Atkins K,
Warnke R, Holden JT, Bray RA, Waller EK and Buck DW: A novel
five-transmembrane hematopoietic stem cell antigen: Isolation,
characterization and molecular cloning. Blood. 90:5013–5021.
1997.PubMed/NCBI
|
|
44
|
Uchida N, Buck DW, He D, Reitsma MJ, Masek
M, Phan TV, Tsukamoto AS, Gage FH and Weissman IL: Direct isolation
of human central nervous system stem cells. Proc Natl Acad Sci USA.
97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
47
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Olempska M, Eisenach PA, Ammerpohl O,
Ungefroren H, Fandrich F and Kalthoff H: Detection of tumor stem
cell markers in pancreatic carcinoma cell lines. Hepatobiliary
Pancreat Dis Int. 6:92–97. 2007.PubMed/NCBI
|
|
49
|
Ossowski L and Aguirre-Ghiso JA: Dormancy
of metastatic melanoma. Pigment Cell Melanoma Res. 23:41–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Suva ML, Riggi N, Stehle JC, Baumer K,
Tercier S, Joseph JM, Suvà D, Clément V, Provero P, Cironi L, et
al: Identification of cancer stem cells in Ewing's sarcoma. Cancer
Res. 69:1776–1781. 2009. View Article : Google Scholar : PubMed/NCBI
|
